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Abstract
Background We examine whether the lung cancer risk
due to smoking has increased over time.
Methods Lung cancer risk equations based on prospective
mortality data collected from 1960 to 1972 were applied to
5-year birth-cohort-speciﬁc estimates of smoking behaviors
among white males to estimate lung cancer mortality rates
for U.S. white males from 1960 to 2000. These estimated
rates were compared to U.S. white male mortality rates for
the same birth cohorts.
Results Observed birth-cohort-speciﬁc U.S. lung cancer
mortality rates are substantially higher than those expected
from changes in smoking behaviors, and the proportional
difference increases with advancing calendar year. This
trend persisted even when the duration term was increased
in the risk equation. However, adjusting for changes in
cigarette design over time by adding a term for the duration
of smoking after 1972 resulted in the predicted rates clo-
sely approximating the observed U.S. mortality rates.
Conclusion Lung cancer risk estimates observed during
the 1960s under predict current lung cancer mortality rates
in U.S. white males. Adjustment for the duration of
smoking after 1972 results in estimates that reasonably
approximate the observed U.S. lung cancer mortality,
suggesting that lung cancer risks from smoking are
increasing in the United States coincident with changes in
cigarette design.
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Introduction
Cigarette smoking is responsible for 85–90% of the lung
cancer occurring in the United States [1]. Epidemiological
data suggest that the risks of smoking for lung cancer
may be increasing. Risks for lung cancer among smokers in
the 6-year follow-up of the Cancer Prevention Study II
(CPS II) begun in 1982 and are substantially higher than
those observed among smokers two decades earlier in the
Cancer Prevention Study I (CPS I) which began in 1959,
even when differences in intensity and duration of smoking
are controlled in the analyses [2]. Risks for never smokers
were similar in the two studies [3] and have remained
unchanged over time [4]. An increased risk of smoking for
lung cancer is also observed when the second 20 years of
follow-up of the British Physicians study is compared to
the ﬁrst 20 years [5]. Changes in cigarette design and
smoke composition over the past several decades have
been suggested as a likely cause of this increase in the lung
cancer risk of smoking [2, 6, 7].
We hypothesize that lung cancer risks due to cigarette
smoking have increased over the period from 1960 to 2000
coincident with known changes in cigarette design [8].
Data from the 12-year follow-up of CPS I provide smoking
behavior–based predictions of lung cancer mortality risks
[9, 10] using observations of lung cancer risk obtained
during the 1960s. These risk equations are applied to 5-year
birth-cohort-speciﬁc estimates of smoking behaviors for
U.S. white males over time in order to estimate the changes
in lung cancer rates expected due to changes in smoking
behaviors. We compare the resulting estimates to observed
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cohorts in the calendar years from 1960 to 2000. Differ-
ences between the estimated and observed lung cancer
rates are examined for trends across calendar year.
White males were selected for these analyses because
CPS I has substantially fewer lung cancer deaths among
women, or among African Americans, making the devel-
opment of risk equations for smoking behaviors in the
1960s for these groups less reliable and more difﬁcult to
interpret.
Methods
Lung cancer risk model
We use published risk equations derived from the lung
cancer mortality experience of white males in the 12-year
follow-up of CPS I to estimate lung cancer risks for active
smokers. These equations have terms for age, duration of
smoking, and number of cigarettes smoked per day [9, 10].
Excess risk equations based on CPS I data extend these risk
equations to include risks for former and never smokers
[9]. The risks for never smokers, current smokers, and
former smokers can be summed to generate an estimate of
the lung cancer death rate for a 5-year birth cohort of white
males by single calendar year once smoking behaviors and
age for the birth cohort are speciﬁed.
Birth-cohort-speciﬁc estimates of smoking behavior
Estimates of smoking initiation, prevalence, and cessation
among white males by 5-year birth cohorts born between
1900 and 1954 were developed for individual calendar
years in conjunction with the National Cancer Institute
Cancer Intervention and Surveillance Modeling Network
(CISNET). A database combining questions on smoking
behavior from all of the National Health Interview Surveys
from 1965 to 2005 and methods previously described [11,
12] is used to generate the estimates. For each calendar
year, these estimates provide rates of smoking initiation,
prevalence of current and former smoking, distributions of
duration of smoking, duration of abstinence and number of
cigarettes smoked per day for current and former smokers,
and the duration of abstinence for former smokers. These
smoking behaviors are used to estimate lung cancer death
rates using the lung cancer risk equations.
Actual and estimated lung cancer mortality rates
Observed mortality rates for cancer of the lung and bron-
chus among white males are obtained from the National
Center for Health Statistics (NCHS) by single year of age
and by single calendar year from 1969 to 2003. Rates for a
5-year birth cohort were generated for 5-year birth cohorts
beginning with 1900–1904 and ending with 1950–1954
birth cohort. For the years from 1960 to 1968, we used the
lung cancer mortality rates for white males provided by
Mannino, et al. [13]. Since Mannino used 5-year birth
cohorts that differed from ours by 1 year, the rates were
adjusted by performing regression modeling of the lung
cancer mortality rates from the NCHS against the Mannino
rates for the overlapping calendar years of 1969–1994.
Estimated lung cancer mortality rates are generated by
applying the risk equations for never, current, and former
smokers to the population estimates of smoking behavior
for each calendar year. The smoking behaviors are arran-
ged in cells speciﬁc for smoking status, duration of
smoking, duration of abstinence, and cigarettes smoked per
day. Lung cancer mortality rates are estimated for each cell
using the appropriate risk equation. A summary rate for the
entire cohort in a given year is generated as the average
(weighted by the fraction of the population in the cell) of
the rates in all of the cells for that year.
Adjustments to the estimates
Difference between the mortality in CPS I and U.S.
mortality
Lung cancer mortality for a healthy population such as that
in CPS I is expected to be lower than that for the general
U.S. Population, sometimes referred to as a healthy popu-
lation selection bias[14]. We use a power function to adjust
the predicted mortality rates upward to match the estimated
mortality rates to the U.S. mortality. We estimate the
parameters for this function by ﬁtting the predicted rates
(^ R) to the observed rates (R) using nonlinear regression to
derive a1 and b1:
R ¼ a1 ^ Rb1
Differences due to increases in the risk of smoking
We also perform an adjustment to capture the potential
effect of an increased risk in smoking after time t0.W e
scale upward the risk of lung cancer for continuing
smokers and former smokers by incorporating a term for
the number of years smoked after t0:
^ R
0
S ¼½ cðt   t0Þ 
It ^ RS
where
It ¼
1; cðt   t0Þ 1
0; cðt   t0Þ\1

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123^ RS ¼ the lung cancer risk estimated from the CPS 1 risk
equations for continuing smokers; t = current calendar
year.
Since the adjustment for duration of smoking after t0 is
only used in the equation when it is greater than or equal to
1, the adjustment can only increase the predicted rate of
lung cancer mortality.
The analogous equations for former smokers are
^ R
0
FS ¼ cðt   t0   tQÞ ½ 
It ^ RFS
where
It ¼
1; cðt   t0   tQÞ 1
0; cðt   t0   tQÞ\1

^ RFS = the lung cancer risk estimated from the CPS 1 risk
equations for former smokers; tQ = the year in which the
former smoker quit smoking.
The predicted lung cancer mortality rate for the cohort
in a speciﬁed year is adjusted for the difference between
the mortality in CPS I and that for the U.S. population
using the power function described earlier with the
resulting equation being:
R ¼ a2 ^ pNS ^ RNS þ ^ pS ^ R
0
S þ ^ pFS ^ R
0
FS
 b2
Nonlinear regression is used to estimate the parameters a2,
b2, and c simultaneously. Estimation of the parameters was
performed manually by iterating t0 in 5-year increments
while estimating one set of a2, b2, and c for each increment
until the variance, estimated by the mean squared error,
was minimized.
Results
The question of whether the risks of smoking have
increased over time is examined by generating birth-
cohort-speciﬁc lung cancer death rates for white males
based on the risks observed during the 1960s (CPS I) and
the changes in smoking behaviors for white males over
the interval 1960–2000. As would be expected [14], the
lung cancer death rates predicted from the smoking spe-
ciﬁc risks observed in the somewhat healthier population
followed in the CPS I are lower than those observed in
the U.S. mortality data. However, the pattern of under-
estimation varies with calendar year and birth cohort.
Figure 1 presents ratios of the observed U.S. lung cancer
death rates to those estimated for the same birth cohort in
the same calendar year. These ratios are presented by
single calendar year and mean year of age for the cohorts
in Fig. 1.
The data in Fig. 1 demonstrate increases in the ratios
with advancing calendar year and age. In both the age and
calendar year plots, the data segregate by birth cohort with
the most recent cohorts having the lowest ratios in the
calendar year plot and the highest ratios in the age plot.
Neither age nor calendar year seems to fully explain the
difference by birth cohort.
The data in Fig. 1 are for all 5-year birth cohorts born
after 1900. In order to minimize the potential contribution
of over-reporting of duration of exposure in the earliest
cohorts and to minimize the effects of the adjustment of
differential mortality on ever smoking prevalence, we limit
subsequent analyses to birth cohorts born after 1915.
Fig. 1 Ratio of observed to
predicted age-speciﬁc, and
calendar year–speciﬁc lung
cancer death rates for 5-year
birth cohorts born 1900–1954
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and the U.S. mortality
We initially explore whether adjusting for the expected
healthy population bias in the CPS I data reduce the trends
with age and calendar year seen in Fig. 1. This difference
might be expected to be disproportionately larger at older
ages where high rates of disease occur, and so we use a
power function to make this adjustment with the equation:
R ¼ a1 ^ Rb1
The birth cohort data for estimated lung cancer death rates
(^ R) are ﬁt to the observed rates (R) to derive the parameters
a1 and b1 using all of the calendar years available for the
birth cohorts born after 1915.
Adjustment for a healthy population bias using this
approach reduces the absolute difference in lung cancer
mortality rates, but substantive trends remained by calendar
year and birth cohort. Figure 2 presents standardized
residuals of the differences between these adjusted
estimates and the observed lung cancer U.S. mortality rates
by calendar year, and it is evident that substantive differ-
ences remain across birth cohorts and that there is a marked
trend from negative to positive residuals with advancing
calendar year after approximately 1980.
Adjusting for differences with calendar year
We next examined whether adjusting for an increasing
toxicity over time of the cigarettes smoked could explain or
reduce the trends with time observed in Figs. 1 and 2.
Examination of the data in Fig. 1 by calendar year suggests
that there is a shift of approximately 5 years in the point
where the lines cross a value of 1 for sequential birth
cohorts born after 1930, and when the values for the ratios
are plotted by the duration of smoking likely to have
occurred after 1945 or 1950, the lines for the different birth
cohorts are roughly superimposed on one another (data not
shown). This observation led us to examine whether
adjusting for the duration of smoking after a deﬁned cal-
endar year, as might be expected from the changes in
cigarette design, could explain the time trends seen in
Figs. 1 and 2.
In order to keep the adjustment for calendar year as
simple as possible, we introduced a single additional term
into the risk equations used to estimate the increase in risks
for both current and former smokers. That term is a con-
stant c which is multiplied by the number of years of
smoking after a speciﬁed calendar year and is therefore a
proxy for the cumulative contribution of cigarettes smoked
after that date to lung cancer risk. For example, someone
born in 1915 who started to smoke in 1930 would have
50 years of smoking duration in 1980, but their duration of
smoking after a speciﬁed year of 1945 would be only
35 years. The speciﬁed trigger year and the value of c are
required to be identical for current smokers and former
smokers in the risk estimation. In addition, since the intent
of this adjustment was to increase the estimated risk, the
adjustment was only applied when the term c*duration-
after-trigger-year exceeded a value of one.
Fig. 2 Standardized residuals for the differences between estimated
and observed white male lung cancer mortality rates by birth cohort
after adjusting for a healthy population bias
Table 1 Parameter estimates for calendar year adjustment for different t0
t0 = 1,940 t0 = 1,945
a t0 = 1,950 t0 = 1,955
Parameter Estimate Estimate 95% CI Estimate Estimate
a 0.95 0.78 (0.73–0.82) 0.65 0.57
b 1.06 1.13 (1.11–1.14) 1.17 1.20
c 0.038 0.036 (0.035–0.037) 0.038 0.042
MSE 135.7
78.25
92.59 153.3
a Best ﬁt
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ences between CPS I and the U.S. mortality (a2, b2) and
c which reﬂects the increasing toxicity of smoking were
derived for each of four trigger years by ﬁtting the
estimated rates to the observed U.S. mortality rates.
Values of the parameter estimates for four trigger years
(t0) are presented in Table 1. The trigger year with the
best ﬁt was 1945. Since the estimates are applied only
when the term—c times the duration of smoking after
the trigger year—exceeds a value of 1, the adjustments
are applied only after 1972 and 27 years duration of
smoking.
The results of adjusting the estimated rates for an
increase in the toxicity of cigarettes over time are presented
in Fig. 3 for each 5-year birth cohort born between 1915
and 1949. Rates are presented by single calendar year for
the unadjusted estimates based on the CPS I risk equations,
for the estimated rates adjusted for both the healthy pop-
ulation bias and a calendar year effect, and for the observed
U.S. mortality. With the inclusion of the adjustment for
increasing toxicity over time, it appears that the estimates
closely match the observed U.S. mortality.
Figure 4 is an identity plot comparing the adjusted
estimated rates and the observed U.S. mortality rates for all
of the cohorts born after 1915 for ages 40–79 and calendar
years 1960–2000. The values are closely grouped around
the line of identity.
As might be expected from the data in Fig. 4, stan-
dardized residuals plotted against calendar year showed
some oscillation around the zero value, but the birth-
cohort-speciﬁc pattern and trend of increasing residual with
increasing calendar year evident in the unadjusted data are
no longer evident.
Fig. 3 Lung cancer death rates estimated from CPS I risk equations before and after adjusting for calendar year effects compared to the observed
U.S. mortality rates for 5-year birth cohorts of white males by calendar year
Fig. 4 Identity plot comparing predicted and observed lung cancer
mortality rates
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ment for the duration of smoking after 1972 (i.e., a trigger
year of 1945 plus 27 years) results in a reasonable match
between the estimates derived and the observed U.S.
mortality for lung cancer in white males.
Adjustments for underestimation of duration effects
in CPS I
A potential alternate explanation for the increase in risk
observed between CPS I and CPS II [2] is an underestimate
of the effect of duration of smoking due to over-reporting
of smoking duration in CPS I. The transition from other
forms of tobacco use to cigarette use largely began after
1914 [11], and much of the lung cancer occurrence in CPS
I was observed among individuals who reported initiating
cigarette smoking before 1914. It is possible that some of
these individuals may have reported their cigarette smok-
ing duration as beginning with their ﬁrst use of any form of
tobacco leading to a longer reported duration of cigarette
smoking than actually occurred. This erroneous reporting
of a longer duration of smoking could lead to a reduced
magnitude for the effect of duration of smoking on lung
cancer risk in the CPS I risk equations. Since a much larger
fraction of those who developed lung cancer in CPS II took
up smoking after 1914, the effect of this form of over-
reporting of duration of smoking would be less, the mag-
nitude of the duration term would increase, and the risk of
smoking would appear to have increased between the two
studies when adjusted for differences in reported duration
of smoking. An underestimation of the magnitude of the
contribution of duration of smoking to lung cancer risk
could also lead to a progressively increasing underestima-
tion of lung cancer rates for the U.S. population as calendar
year advanced and the cumulative duration of smoking in
the population increased.
We examined the potential for an underestimation of the
effect of duration on risk to explain our observation of
progressively increasing underestimate of U.S. mortality
with advancing calendar year. We systematically altered the
exponent for the duration term in 0.1 increments and
decrements and compared the new estimates for birth-
cohort-speciﬁc risks to the observed U.S. mortality rates
using the previously derived values for the adjustments for
the differences between CPS I and the U.S. mortality (the a1
and b1) parameters. The best ﬁt for the duration increments
(2.9)varied littlefromtheonederived directlyfromtheCPS
I data (2.87), and the pattern of the residuals continue to
demonstrateclearcohorteffectsandprogressiveincreasesin
the standardized residuals with increasing calendar year.
We also examined this question by selecting the best
ﬁtting increment in the duration exponent without utilizing
the a1 and b1 parameters and then deriving new. a1 and b1
parameters by re-ﬁtting the estimates to the observed lung
cancer mortality rates. This resulted in a somewhat greater
increase in the duration exponent producing the best ﬁt (to
3.1), but the resulting residuals continued to display cohort
and calendar year effects as presented in Fig. 5.
These results demonstrate that in contrast with adjust-
ments for increasing toxicity of the cigarette smoked,
simple adjustments of the duration effect in the CPS I risk
equations do not provide reasonable estimates of the U.S.
lung cancer mortality experience.
Discussion
It may be tempting for the reader to consider this paper as a
presentation of a model for predicting U.S. lung cancer
mortality. However, that is not our intent. Our intent is to
take a set of simple risk equations shown to predict lung
cancer rates well in a large epidemiological study con-
ducted during the 1960s and examine the changes in how
well the estimates from these risk equations continue to
predict observed U.S. lung cancer mortality in white males
over the subsequent decades. We then explore the effect of
simple adjustments for those factors postulated to explain
the difference in risk estimates between CPS I and CPS II
and the under prediction of U.S. mortality rates including: a
healthy population effect, changes in the risks of smoking
over time, and an underestimate of the duration effect in
the CPS I data. Of these, adjusting for an increase in the
risk of smoking over time was the only simple adjustment
which resulted in estimates that matched the changes in
lung cancer risks for the U.S. population of white males
over the past several decades.
Rates of lung cancer mortality among nonsmokers have
been examined for changes over time and found to be
Fig. 5 Standardized residuals for the estimates from the CPS I risk
equations with the duration exponent increased to 3.1 and new a1 and
b1 parameters
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123relatively constant across calendar year [3, 4], suggesting
that the changes in risk observed in our analyses are con-
ﬁned to smokers and are unlikely to be the result of
changes in other risk factors for lung cancer.
Our goal is to further test the hypothesis that changes in
cigarette design may have made smoking more dangerous
over the past half century. We support that hypothesis by
showing that even a simple adjustment of the CPS I risk
equations for an increase in risk due to changes in ciga-
rettes adequately predicts the observed mortality data.
Adjustments for healthy population effects and for poten-
tial underestimates of the contribution of duration to risk
are not able to eliminate either the differences in estimation
accuracy across birth cohorts or the progressive underes-
timate of observed lung cancer mortality as calendar year
advances.
The possibility that increasing lung cancer rates over
time in birth cohort analysis is due to diagnostic advances
has been examined by others and not felt to explain these
trends [7, 15, 16]. While shifts in the age distribution of the
population over time may contribute to increases in age
adjusted lung cancer rates, they would not have a mean-
ingful impact on the birth-cohort-speciﬁc rates we present.
Since the estimates are based on the distribution of
smoking behaviors at the start of each calendar year, dif-
ferences in competing cause mortality over time will also
have little effect. Shifts in the socioeconomic distribution
of smokers over time could contribute to an increase in
overall lung cancer death rates, but that shift should be
relatively uniform across the birth cohorts and that is not
what we observed. In addition, a companion analysis [17]
of type-speciﬁc lung cancer risks demonstrates that the
increase in lung cancer risk is predominantly for adeno-
carcinoma which is more difﬁcult to explain as a socio-
economic effect. Recent data [18] also suggest that there
may be a slower decline in death rates from adenocarci-
noma of the lung than compared to squamous and small
cell carcinomas, ant this may increase that proportion of all
lung cancer that is adenocarcinoma as former smokers
represent a larger proportion of the ever smoking popula-
tion. Since our adjustment of the risk following cessation is
based on the observed risks with different durations of
abstinence in the CPS I follow-up, the effect of slower
decline in adenocarcinoma rates would have been incor-
porated into the estimates of the overall decline in lung
cancer rates. The limited analyses that address the issue of
a shifting socioeconomic effect over time suggest that
shifts in the social class of smokers has less effect on trends
in adenocarcinoma than for the other types of lung cancer
[19].
Models of risk based on smoking pattern have been
applied by others to birth-cohort-speciﬁc smoking preva-
lence data in order to estimate the expected occurrence of
lung cancer in the absence of any change in the risk of
smoking. Swartz [20] used birth-cohort-speciﬁc smoking
prevalence data and a multi-stage carcinogenesis model
similar to that developed by Whittemore [21] to predict
overall age-adjusted trends in lung cancer mortality for
white males from 1970 to 1985. He estimated that there
should have been a 12% decline in rates over the interval
based on the assumption of a constant effect over time in
the risk model. This estimated decline contrasts sharply
with the 26% increase in the observed lung cancer mor-
tality rates over that interval. Tolley and colleagues [22]
used an updated set of birth cohort smoking prevalence
estimates, and a risk model developed by Peto [23], to
predict lung cancer death rates over time by birth cohort.
They estimated that overall lung cancer mortality should
have begun to decline in the early 1980s for white males
and in the mid-1990s for white females. Observed lung
cancer mortality continued to rise throughout the 1980s
peaking in the early 1990s for white males [24] and may
have only recently peaked for white females [25]. A similar
approach using risk models developed from the CPS I data
and birth-cohort-speciﬁc smoking prevalence data from the
National Health Interview Survey (NHIS) demonstrated a
systematic trend of increasing underestimation of observed
lung cancer mortality rates across all birth cohorts with
advancing calendar year [6]. None of these analyses
included adjustment for changes in number of cigarettes
smoked per day over time. We believe our analyses are the
ﬁrst to include the effect of differences in cigarettes
smoked per day.
When considering the increase in lung cancer risk
between CPS I and CPS, the possibility of underestimating
both CPD and duration effects was considered [2]. Exam-
ination of patterns of per capita consumption and smoking
behaviors in the early years of the last century suggest that
cigarette smoking was uncommon in the U.S. prior to 1914,
particularly in relation to other forms of tobacco use [11].
Since lung cancer is a disease of older ages, much of the
lung cancer mortality experience in CPS I occurred among
males who were well past their adolescence by 1914, and
yet many of them report initiating smoking at early ages. It
is therefore possible that some of these individuals reported
initiating cigarette smoking at the time that they ﬁrst used
tobacco of any type or otherwise overestimated their
duration of cigarette smoking. This may also result in an
overestimation of the number of cigarettes smoked early in
life.
Overestimation of duration of smoking in CPS I data
would result in an underestimate of the contribution of
duration to lung cancer risk in the risk equations. Since it is
exponential in effect, it is not hard to contemplate that a
substantive underestimate of the contribution duration from
CPS I could lead to both an increase between CPS I and II
Cancer Causes Control (2011) 22:389–397 395
123and the increasing underestimate of U.S. mortality seen in
our analyses. Nevertheless, our results suggest that is not
that case. While increasing the duration term does increase
the estimated rates, as it must, the pattern remains one
where there is a progressive change as calendar year
advances with an overestimate of the actual risk giving way
to an underestimate of the risk. Simply increasing the
contribution of the duration term does not resolve the
changes over time. It is possible that more sophisticated
approaches to modeling or more complex adjustments
could resolve the temporal trend differences, but even the
complex two stage clonal expansion models used by the
NCI CISNET effort have required age period cohort
adjustments to match U.S. mortality rates.
The contribution of cigarettes smoked per day to lung
cancer risk is much smaller than the contribution of dura-
tion [10, 26], and the exponent for the cigarettes per day
term in the CPS I risk equations is close to 1. As a result,
underestimation of lifetime number of cigarettes smoked
per day due to over-reporting of smoking early in life
would be expected to make only a modest contribution to
mis-estimation of the risk and that mis-estimation should
largely be absorbed by the constant parameter used to
adjust for healthy populations (a1), since the effect would
be approximated by a constant. The effect of an overesti-
mate of duration in the CPS I data would be expected to be
larger since the exponent on the duration term in the risk
equation is large (2.87).
There have been substantial changes in cigarette design
and manufacture over to past several decades [8] including
the addition of ﬁlters to cigarettes, using ventilation holes
in those ﬁlters to lower machine estimates of tar exposure,
a substantial increase in the carcinogenic tobacco-speciﬁc
nitrosamines in cigarettes [27] as well as other changes [8].
Ventilated ﬁlters increase the puff volume used by the
smoker and may lead to deeper inhalation of the smoke
increasing the smoke exposure to the lung [28]. Increasing
nitrosamine levels may make the smoke more carcinogenic
at any level of exposure. Widespread shift to ﬁltered cig-
arettes occurred in the 1950s and changes in the nitrosa-
mine levels date from the 1960s [8, 29]. Our data do not
allow differentiation between these two potential mecha-
nisms for an increased risk of smoking over time.
These analyses rely on risk equations, survey estimates
of smoking behavior, and U.S. mortality data; and no
individual level information linking smoking behaviors to
lung cancer outcomes is utilized. As such, the results of our
analyses can be used for hypothesis generation and support,
but they should not be considered as proving causation. As
with any analyses of this type, there is always a potential
for misspeciﬁcation or inaccuracy in the underlying data to
confound the results.
Our data demonstrate an increase in the risk associated
with smoking over the past several decades as estimated
using risk equations developed from smokers during the
1960s and changes in smoking behaviors from national
surveydata.Adjustmentoftheriskequationsfortheduration
of smoking after 1972 allows the estimates to reasonably
approximate the observed U.S. lung cancer mortality expe-
rience, butsimpleadjustmentsforthe effectoftotalduration
of smoking does not. These results support the hypothesis
thatlungcancerrisksfromsmokingmaybeincreasinginthe
U.S.duetochangesincigarettedesign, andcorrespondingly
that regulatory control over cigarette design may have the
potential to reduce the risk of smoking. While not conclu-
sive,ourresultssuggestthatthepotentialforincreasinglung
cancerriskfromchangesincigarettedesignoverthepasthalf
century should be explored more fully.
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